Press Releases

Healthcare SPDR ETF (NYSE: XLV) Flourishes Amid Bill Controversy
The Healthcare SPDR ETF (NYSE: XLV) is near a new high despite the seeming threat of profit losses ahead for the sector based on health care "reform."



Chart Courtesy of StockCharts.com


Either health care investors know something or those who are pushing the sector higher are getting the rally out of their system before whatever changes that are coming make their way into the system.

XLV is moving nicely higher, which suggests that investors are betting that whatever comes out of Congress will so watered down that it won't make much difference tocompany earnings. And if that's the case what do investors know?

It's hard to figure. But maybe it's that even this late in the game some senators are saying that they won't vote for the plan. Or maybe it's the thought that some 30 million new paying customers will be added to the potential profit rolls.

If it's the latter, then the price increases that the pharmaceutical companies have put in place, as well as the way that drug stores have passed them through to customers, even on generic drugs, signal what's likely to be in the future.

If that's the bottom line, then we can see where the new highs on XLV have come from, the expectations for even more profits ahead as more people pay even higher prices for prescription medicines and likely even for other services.

Make money if any market rises or falls, with a copy of "Market Timing For Dummies."

“Futures And Options For Dummies,” Dr. Duarte’s latest book is now available. The markets are responding to news and geopolitical developments like never before. In this environment, individual investors need to expand their investment horizons. "Futures And Options For Dummies " (John Wiley & Sons) has an excellent section on oil futures as well as the currency markets, while covering and expanding on the successful strategies in Doctor Duarte's other books. Order your copy today.

Doctor Joe Duarte's Market I.Q., offers subscribers a unique blend of intelligence, market commentary and trading strategy. Duarte's daily articles, and news summaries offer recommendations and analysis for ETFs, and individual stocks in the technology, health and biotechnology, and energy sectors. Doctor Duarte is a writer, and an emerging futurist, with a diverse background, and a growing audience. His combined expertise in health care, energy, and the effects of politics and global intelligence on the financial markets offer a unique blend of insight and information to thousands of active investors and political and intelligence aficionados around the world on a daily basis.

He is the author of four books: "Futures And Options For Dummies," "Successful Energy Sector Investing," "Successful Biotech Investing" and co-author of "After-Hours Trading Made Easy."

In early 2001 Dr. Duarte in "Successful Energy Sector Investing," correctly predicted that Venezuela's political problems could lead to an energy crisis in the United States.

In 2003, also Dr. Duarte was among the first to widely publicize the long-term friendship between French President Jacques Chirac and Saddam Hussein.

He has also appeared as a weekly guest on Market Mavens Radio, has logged appearances on KNX radio in Los Angeles, Financial Sense.com radio, and Wall Street Radio.

One of CNBC's original Market Mavens, Dr. Duarte has been writing about the financial markets since 1990.

His articles and commentary have been featured on CBS Marketwatch, Barron's, Smart Money, Medical Economics, and in Technical Analysis of Stocks and Commodities magazines.

In 2003, Doctor Duarte received second place, in the professional section, of the Medical Economics Investment Challenge with a 12-month return of 42%.




Joe-Duarte.com is independently operated and solely funded by subscriber fees. This web site and the content provided is meant for educational purposes only and is not a solicitation to buy or sell any securities or investments. All sources of information are believed to be accurate, or as otherwise stated. Dr. Duarte and the publishers, partners, and staff of Joe-Duarte.com have no financial interest in any of the sources used. For independent investment advice consult your financial advisor. The analysis and conclusions reached on Joe-Duarte.com are the sole property of Dr. Joe Duarte.